ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,046 filers reported holding ASTRAZENECA PLC in Q3 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,584,658 | +29.2% | 333,408 | +35.7% | 0.03% | +6.5% |
Q2 2023 | $17,485,029 | -7.7% | 245,760 | -9.7% | 0.03% | -13.9% |
Q1 2023 | $18,938,833 | +24.6% | 272,118 | +21.5% | 0.04% | +16.1% |
Q4 2022 | $15,194,692 | +37.3% | 224,050 | +11.1% | 0.03% | +24.0% |
Q3 2022 | $11,063,000 | -8.4% | 201,655 | +10.5% | 0.02% | -7.4% |
Q2 2022 | $12,073,000 | +5.5% | 182,536 | -7.9% | 0.03% | +22.7% |
Q1 2022 | $11,441,000 | +11.6% | 198,148 | +12.7% | 0.02% | +15.8% |
Q4 2021 | $10,248,000 | -4.1% | 175,865 | -1.2% | 0.02% | -13.6% |
Q3 2021 | $10,686,000 | +26.4% | 177,978 | +25.0% | 0.02% | +22.2% |
Q2 2021 | $8,453,000 | +32.6% | 142,415 | +11.0% | 0.02% | +20.0% |
Q1 2021 | $6,376,000 | -11.8% | 128,248 | -11.4% | 0.02% | -21.1% |
Q4 2020 | $7,232,000 | +0.8% | 144,731 | +10.4% | 0.02% | -9.5% |
Q3 2020 | $7,172,000 | +20.7% | 131,056 | +16.8% | 0.02% | +5.0% |
Q2 2020 | $5,941,000 | +40.8% | 112,191 | -31.3% | 0.02% | +17.6% |
Q1 2020 | $4,219,000 | – | 163,188 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |